Pacira Biosciences leads in non-opioid pain relief with Exparel & upcoming knee osteoarthritis therapy. Click here to read my ...

4Moving Biotech (4MB), a spin-off of 4P-Pharma developing the first potential disease-modifying drug (DMOAD) for knee osteoarthritis, announces that it has been awarded €7.6 million in funding under ...

Cytonics, an early-stage biopharmaceutical company developing therapies for osteoarthritis, today announced that the last ...

Ben Yole. Picture: Supplied The panel found him guilty of the mistreatment charge, not guilty of the first intra-articular injection charge, and guilty of the third injection charge. Mr Yole was ...

Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

Intra-articular injections, used to treat inflammation and pain, are not permitted within 14 days of a race or seven days of a workout, under rules administered by the Horseracing Integrity and ...

Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has successfully passed the GMP on-site inspection by South Korea's ...

PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging biomedical device company focused ...

If possible, meta-analysis was performed. Results Ten trials were included. In these, intra-articular PRP injections were more effective for pain reduction (mean difference (MD) −2.45; 95% CI −2.92 to ...